Found 2540 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
J Alexander, W., Metze, T. J., McIntosh, M. J., Goodman, H. R., M First, R., Munda, R., et al.. (2005). The influence of immunomodulatory diets on transplant success and complications. Transplantation, 79(4), 460-5. presented at the 2005 Feb 27. doi:10.1097/01.tp.0000148802.04879.27
Allen, C. A., Yesko, L., & Van Veldhuisen, P.. (2014). Implications of Modifying Study Eligibility Criteria Post-Initiation of Recruitment. In Society for Clinical Trials 35th Annual Meeting. presented at the 19/05/2014, Philadelphia, PA. Retrieved from http://www.sctweb.org/public/meetings/2014/home.cfm
Allen, C. E., Marsh, R., Dawson, P., Bollard, C. M., Shenoy, S., Roehrs, P., et al.. (2018). Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. Blood, 132(13), 1438-1451. presented at the 2018 09 27. doi:10.1182/blood-2018-01-828277
Allen, M., Israel, H., Rybczyk, K., Pugliese, M. A., Loughran, K., Wagner, L., & Erb, S.. (2001). Trial-related discrimination in HIV vaccine clinical trials. AIDS Res Hum Retroviruses, 17(8), 667-74. presented at the 2001 May 20. doi:10.1089/088922201750236942
Alonso, E. M., Shepherd, R., Martz, K. L., Yin, W., & Anand, R.. (2009). Linear growth patterns in prepubertal children following liver transplantation. Am J Transplant, 9(6), 1389-97. presented at the 2009 Jun. doi:10.1111/j.1600-6143.2009.02634.x
Ambinder, R. F., Wu, J., Logan, B., Durand, C. M., Shields, R., Popat, U. R., et al.. (2019). Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial. Biol Blood Marrow Transplant, 25(11), 2160-2166. presented at the 2019 11. doi:10.1016/j.bbmt.2019.06.033